Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 28, 2016 - Issue 8
419
Views
37
CrossRef citations to date
0
Altmetric
Articles

Alcohol-antiretroviral therapy interactive toxicity beliefs and daily medication adherence and alcohol use among people living with HIV

, , &
Pages 963-970 | Received 13 Nov 2015, Accepted 07 Feb 2016, Published online: 10 Mar 2016

References

  • Babor, T. F., Higgins-Biddle, J. C., Saunders, J. B., & Monteiro, M. G. (2001). The alcohol use disorders identification test: Guidelines for use in primary care (2nd ed.). Retrieved from http://apps.who.int/iris/handle/10665/67205 (World Health Organization website).
  • Bachman DeSilva, M., Gifford, A. L., Keyi, X., Li, Z., Feng, C., Brooks, M., … Sabin, L. (2013). Feasibility and acceptability of a real-time adherence device among HIV-positive IDU patients in China. AIDS Research and Treatment, 2013, 1–6. doi: 10.1155/2013/957862
  • Bates, D., Maechler, M., Bolker, B., Walker, S., Christensen, R. H. B., Singmann, H., & Dai, B. (2015). Package “lme4: Linear mixed-effects models using Eigen and S4”. Retrieved from Comprehensive R Archive Network http://cran.r-project.org/web/packages/lme4/index.html
  • Brock, D., Sarason, I., Sarason, B., & Pierce, G. (1996). Simultaneous assessment of perceived global and relationship-specific support. Journal of Social and Personal Relationships, 13, 143–152. doi: 10.1177/0265407596131008
  • van Buuren, S., & Groothuis-Oudshoorn, K. (2011). Mice: Multivariate imputation by chained equations in R. Journal of Statistical Software, 45(3), 1–67.
  • van Buuren, S., & Groothuis-Oudshoorn, K. (2015). Mice: Multivariate imputation by chained equations. Retrieved from http://cran.r-project.org/web/packages/mice/index.html (Comprehensive R Archive Network).
  • Conen, A., Wang, Q., Glass, T. R., Fux, C. A., Thurnheer, M. C., Orasch, C., … Fehr, J. (2013). Association of alcohol consumption and HIV surrogate markers in participants of the Swiss HIV cohort study. Journal of Acquired Immunodeficiency Syndromes, 64(5), 472–478. doi: 10.1097/QAI.0b013e3182a61ea9
  • Egger, M., May, M., Chene, G., Phillips, A. N., Ledergerber, B., Dabis, F., … ART Cohort Collaboration. (2002). Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. The Lancet, 360(9327), 119–129. doi: 10.1016/S0140-6736(02)09411-4
  • European Collaborative Study, Patel, D., Cortina-Borja, M., Thorne, C., & Newell, M. L. (2007). Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. Clinical Infectious Diseases, 44(12), 1647–1656. doi: 10.1086/518284
  • Georgia Department of Public Health. (2012). HIV/AIDS surveillance, Georgia, 2012. Retrieved August 17, 2015, from https://dph.georgia.gov/data-fact-sheet-summaries
  • Grodensky, C. A., Golin, C. E., Ochtera, R. D., & Turner, B. J. (2012). Systematic review: Effect of alcohol intake on adherence to outpatient medication regimens for chronic diseases. Journal of Studies on Alcohol and Drugs, 73(6), 899–910. doi: 10.15288/jsad.2012.73.899
  • Haberer, J. E., Kahane, J., Kigozi, I., Emenyonu, N., Hunt, P., Martin, J., & Bangsberg, D. R. (2010). Real-time adherence monitoring for HIV antiretroviral therapy. AIDS and Behavior, 14(6), 1340–1346. doi: 10.1007/s10461-010-9799-4
  • Horne, R., Buick, D., Fisher, M., Leake, H., Cooper, V., & Weinman, J. (2004). Doubts about necessity and concerns about adverse effects: Identifying the types of beliefs that are associated with non-adherence to HAART. International Journal of STD and AIDS, 15, 38–44. doi: 10.1258/095646204322637245
  • Horne, R., Cooper, V., Gellaitry, G., Date, H. L., & Fisher, M. (2007). Patients’ perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: The utility of the necessity-concerns framework. Journal of Acquired Immune Deficiency Syndromes, 45, 334–341.
  • Kalichman, S. C., Amaral, C. M., White, D., Swetsze, C., Kalichman, M. O., Cherry, C., & Eaton, L. (2012). Alcohol and adherence to antiretroviral medications: Interactive toxicity beliefs among people living with HIV. Journal of the Association of Nurses in AIDS Care, 23(6), 511–520. doi: 10.1016/j.jana.2011.11.005
  • Kalichman, S. C., Amaral, C. M., White, D., Swetsze, C., Pope, H., Kalichman, M. O., … Eaton, L. (2009). Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Patient Care and STDs, 23(6), 449–454. doi: 10.1089/apc.2008.0184
  • Kalichman, S. C., Grebler, T., Amaral, C. M., McNerney, M., White, D., Kalichman, M. O., … Eaton, L. (2013). Intentional non-adherence to medications among HIV positive alcohol drinkers: Prospective study of interactive toxicity beliefs. Journal of General Internal Medicine, 28(3), 399–405. doi: 10.1007/s11606-012-2231-1
  • Kalichman, S. C., Kalichman, M. O., Cherry, C., Hoyt, G., Washington, C., Grebler, T., … Welles, B. (2015). Intentional medication non-adherence due to interactive toxicity beliefs among HIV positive active drug users. Journal of Acquired Immune Deficiency Syndromes, 70(5), 503–509. doi: 10.1097/QAI.0000000000000776
  • Kalichman, S. C., Rompa, D., & Cage, M. (2000). Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. The Journal of Nervous and Mental Disease, 188(10), 662–670. doi: 10.1097/00005053-200010000-00004
  • Kobin, A. B., & Sheth, N. U. (2011). Levels of adherence required for virologic suppression among newer antiretroviral medications. Annals of Pharmacotherapy, 45, 372–379. doi: 10.1345/aph.1P587
  • Kowalski, S., Colantuoni, E., Lau, B., Keruly, J., McCaul, M. E., Hutton, H. E., … Chander, G. (2012). Alcohol consumption and CD4 T-cell count response among persons initiating antiretroviral therapy. Journal of Acquired Immunodeficiency Syndromes, 61(4), 455–461. doi: 10.1097/QAI.0b013e3182712d39
  • Kresina, T. F., Flexner, C. W., Sinclair, J., Correia, M. A., Stapleton, J. T., Adeniyi-Jones, S., … Cheever, L. W. (2002). Alcohol use and HIV pharmacotherapy. AIDS Research and Human Retroviruses, 18(11), 757–770. doi: 10.1089/08892220260139495
  • Meyerhoff, D. J. (2001). Effects of alcohol and HIV infection on the central nervous system. Alcohol Research and Health, 25(4), 288–298.
  • Parsons, J. T., Rosof, E., & Mustanski, B. (2008). The temporal relationship between alcohol consumption and HIV-medication adherence: A multilevel model of direct and moderating effects. Health Psychology, 27, 628–637. doi: 10.1037/a0012664
  • Pellowski, J. A., Kalichman, S. C., Cherry, S., Conway-Washington, C., Cherry, C., Grebler, T. & Krug, L. (under review). The daily relationship between food insecurity and medication adherence among people living with HIV.
  • Pellowski, J. A., Kalichman, S. C., White, D., Amaral, C. M., Hoyt, G., & Kalichman, M. O. (2014). Real-time medication adherence monitoring intervention: Test of concept in people living with HIV infection. Journal of the Association of Nurses in AIDS Care, 25(6), 646–651. doi: 10.1016/j.jana.2014.06.002
  • R Core Team (2015). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Retrieved from http://www.r-project.org
  • Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401. doi: 10.1177/014662167700100306
  • Sankar, A., Wunderlich, T., Neufeld, S., & Luborsky, M. (2007). Seropositive African Americans’ beliefs about alcohol and their impact on anti-retroviral adherence. AIDS and Behavior, 11, 195–203. doi: 10.1007/s10461-006-9144-0
  • Snijders, T., & Bosker, R. (1999). Multilevel analysis: An introduction to basic and advanced multilevel modeling. London: Sage.
  • Viswanathan, S., Justice, A. C., Alexander, G. C., Brown, T. T., Gandhi, N. R., McNicholl, I. R., … Jacobson, L. P. (2015). Adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy. Journal of Acquired Immuno Deficiency Syndromes, 69(4), 493–498. doi: 10.1097/QAI.0000000000000643

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.